WhichPepsPeptides. Without the hype.
Learn

Frequently asked questions.

Short answers to common orientation questions, grounded in the WhichPeps methodology and regulatory boundaries.

Are all compounds on WhichPeps peptides?

No. The library intentionally includes some adjacent research compounds because users research them together. Each profile should show an explicit entity type.

Does “human evidence” mean a compound is proven?

No. Human evidence ranges from tiny exposure studies and uncontrolled observations to large randomised trials. Design, population, endpoint, route and limitations matter.

Does Phase III mean approved?

No. Phase III is a clinical-development stage. Regulatory approval is a separate product- and jurisdiction-specific decision.

Why do some compounds have several names?

A canonical compound can also have a development code, brand name, formulation name, community shorthand or common misspelling. Search can recognise them without creating duplicate scientific records.

Does WhichPeps recommend a peptide for a goal or condition?

No. WhichPeps summarises evidence and uncertainty; it does not provide personalised treatment recommendations.

Are study doses instructions for me?

No. “Dose studied” describes the study protocol or licensed product label. WhichPeps does not convert those values into patient-specific dosing advice.

Does a mechanism prove a benefit?

No. Receptor activity, cell signalling or biomarker change can be biologically interesting without producing a meaningful clinical outcome.

What is the difference between approved, off-label and unlicensed?

Approval belongs to a specific authorised product and indication. Off-label use is use of an approved product outside authorised conditions. An unlicensed product does not hold the relevant marketing authorisation. Jurisdiction matters.

Does WhichPeps sell peptides or recommend suppliers?

No. The platform is designed to monetise evidence/research utility in the future, not sales or promotion of unlicensed medicines or prescription-only products.

How current is a profile?

Each profile displays an evidence-reviewed date. Page-update dates and evidence-review dates are treated separately.

What should I do if I find an error?

Use the Corrections & Contact route. Material corrections should be reflected in the public change history when appropriate.

Does a registered clinical trial prove a compound works?

No. Registration documents that a study exists and describes its protocol/status. Results may not yet exist or may not be posted or published. WhichPeps treats registration, completion, posted results and peer-reviewed publication as different states.

If two compounds each have evidence, does that prove the stack works?

No. Component evidence does not establish the efficacy, safety, interaction, compatibility or formulation of the combination. Direct combination evidence is tracked separately.

Does a high-purity COA prove a vial is safe or effective?

No. Analytical identity, purity, content, sterility, endotoxin and stability are separate quality questions, and product-quality testing is not clinical efficacy evidence.

Products, vials and pens

Do all peptide vials use bacteriostatic water?

No. Some authorised products specify bacteriostatic water, while other formulations use different diluents or are supplied ready to use. The correct diluent and preparation depend on the exact product and formulation. WhichPeps does not convert research-market instructions into personal-use reconstitution protocols.

See the beginner explanation →

Does a pre-filled pen mean the product is an approved medicine?

No. Approved medicines can use pen devices, but research-market sellers also sell pre-filled pens. Approval belongs to the named product, manufacturer, indication and jurisdiction — not to the pen format.

See formats and brand categories →